7:30 AM – 8:15 AM	Breakfast
Introduction
8:15 AM – 8:20 AM	Stacy L. Springs, MIT CBI view bio
Opening Remarks
8:20 AM – 8:35 AM	Funding Approaches for Incentivizing Innovation and Biomanufacturing Travis A. McCready President and Chief Executive Officer, Massachusetts Life Sciences Center view bio
Keynote Presentation
8:35 AM – 9:20 AM	Human Gene Therapy – The Road to Today and Beyond Guangping Gao Co-Director, Li Weibo Institute for Rare Diseases Research, Director, Horae Gene Therapy Center and Viral Vector Core, Professor of Microbiology and Physiological Systems, Penelope Booth Rockwell Professor in Biomedical Research, University of Massachusetts Medical School view bio | view abstract
Framing the Day
9:20 AM - 9:35 AM	Jacqueline Wolfrum Associate Director, Biomanufacturing Program, MIT CBI view bio
Session 2: New Platforms
	Morning Chair: Jacqueline Wolfrum, MIT CBI view bio
9:35 AM to 10:00 AM	Cell Therapy Manufacturing Platforms: How to Meet Today’s and Tomorrow’s Challenges Gregory Russotti Vice President, Cell Therapy Technical Development, Celgene view bio | view abstract
10:00 AM – 10:25 AM	Refreshment Break
10:25 AM – 10:45 AM	Expansion of Human Induced Pluripotent Stem Cells in Stirred Suspension Culture Aletta Schnitzler Head of Collaborations, Cell Therapy Bioprocessing, MilliporeSigma view bio | view abstract
10:45 AM – 11:10 AM	Beyond Automated iPSC Reprogramming: Applications for a Fully-Automated System Elizabeth Schwarzbach Chief Business Officer, New York Stem Cell Foundation Research Institute view bio | view abstract
11:10 AM – 11:30 AM	High-Titer Lentivirus Production in Suspension Cell Culture Systems Using Transient Transfection Onur Kas Senior Scientist, Virus and Gene Therapy Bioprocessing, MilliporeSigma view bio | view abstract
11:30 AM – 11:55 AM	Technologies for High-Quality Manufacturing of Autologous Cell Therapies Rajeev Ram Professor of Electrical Engineering and Computer Science, MIT view bio | view abstract Harry Lee Co-Founder and President, Pharyx view bio | view abstract
Academic Poster Awards
11:55 AM – 12:15 PM	Presented by: Stephanie Flores, Executive Director, CASSS, John Frenz, Distinguished Fellow, CASSS, and Stacy L. Springs, Executive Director, Biomanufacturing Initiatives; Senior Director of Programs, MIT CBI
12:15 PM – 1:15 PM	Lunch
Session 3: New Challenges
	Afternoon Chair: James C. Leung, MIT CBI view bio
1:15 PM – 1:40 PM	Laser Force Cytology for Label-Free Single Cell Analysis and its Applicability in Cell Therapy Biomanufacturing Colin Hebert Vice President, Biotechnology, LumaCyte view bio | view abstract
1:40 PM – 2:05 PM	Digital Cell Biology At Light Speed Warren Davis Sales Account Manager, Berkeley Lights view bio | view abstract
2:05 PM – 2:25 PM	Analytical Opportunities and Challenges in Developing CAR T-cell Therapies Trent Munro Executive Director of Process Development, Attribute Sciences, Amgen view bio | view abstract
2:25 PM – 2:50 PM	Establish Efficient Approaches to Quantify rAAV Vectors and Build a Robust Path to the Clinic Vivian Choi Director, Head of Gene Therapy Research US, Discovery Therapeutics, US Drug Discovery, Shire view bio | view abstract
2:50 PM – 3:15 PM	Real-Time Microbial Detection for Biomanufacturing Nicholas Brancazio Microbiology Associate, Fluid-Screen view bio | view abstract
3:15 PM – 3:40 PM	Refreshment Break
3:40 PM – 4:05 PM	Critical Attributes of Stem Cells for Therapeutic Efficacy: Engineering and Understanding Manufacturing Implications Krystyn Van Vliet Associate Provost; Michael and Sonja Koerner Professor of Materials Science and Engineering and Professor of Biological Engineering, MIT view bio | view abstract
4:05 PM – 4:30 PM	Challenges and Opportunities in AAV Manufacturing for Gene Therapy Nicole K. Paulk Assistant Professor, Department of Biochemistry & Biophysics, University of California, San Francisco; Visiting Scientist, Genome Engineering, Chan Zuckerberg Biohub view bio | view abstract
4:30 PM – 4:55 PM	Lessons from the CAACB for Cell and Gene Therapy Products Paul W. Barone Director, Biomanufacturing Program and the Consortium on Adventitious Agent Contamination in Biomanufacturing, MIT CBI view bio | view abstract
4:55 PM – 5:20 PM	Coverage and Reimbursement for High-Cost Curative Therapies Casey Quinn Research Advisor, NEWDIGS FoCUS Project, MIT CBI view bio | view abstract
Closing Remarks
5:20 PM – 5:30 PM	Stacy L. Springs Executive Director, Biomanufacturing Initiatives; Senior Director of Programs, MIT CBI view bio